SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vaishali Pharma enters into licensing agreement with U.S.A. Healthcare market

04 Jan 2021 Evaluate

Vaishali Pharma has entered into licensing agreement with U.S.A. Healthcare Market for the Healthcare Products. Exposure to International Market in catering Quality Products, has fetch a new set of business for company from U.S.A. Healthcare Market. Initially 5 Products have been finalized to be sourced for the U.S.A. Healthcare Market as per the In Licensing Agreement for the Healthcare Products.

The Company is striving hard to double the product range in various countries in coming years and working in that direction consistently.

Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets.

Peers
Company Name CMP
Redington 227.35
Adani Enterprises 2225.25
Amrapali Industries 17.27
Rashi Peripheral 474.40
PDS 291.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×